Molecular Diagnostics Market 2017 -Current Trends, Development and Potential of Industry till 2023

The report titled “Molecular Diagnostics Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Molecular Diagnostics Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! Global molecular diagnostics market is expected to grow at a CAGR of 9.6% during forecasted period 2017-2023.

MarketResearchFuture.com adds “Molecular Diagnostics Market -2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

Regional Analysis:

On the basis of regional analysis, global molecular diagnostics market is segmented into America, Europe, Asia Pacific and Middle East & Africa. America accounts for the major share of the market for molecular diagnostics followed by Europe and Asia Pacific. Increasing prevalence of chronic diseases and various types of cancer, and huge investment in research sector and treating diseases has improved growth of market. Europe accounts second largest share of market due to increase demand for biomarker test to diagnose cardiovascular disease as number of obese people. The European molecular diagnostics market has observed stable growth owing to increasing demand for advanced molecular diagnostic products.

Asia-Pacific is fastest growing market region for this market. Presence of large number of low budget hospitals and clinics and huge population base are responsible for growth of this market in Asia Pacific.

Middle East & Africa has a limited growth in the market due to lack of awareness among the people and limited development of medical sector.

According to American Cancer Society, Asia Pacific region, contributes 44% of all cancer cases (6.4 million out of 14.1 million) and 51% of all cancer deaths (4.3 million out of 8.2 million) globally, whereas China representing the majority of the cancer burden. Incidence rates vary, being highest in the Republic of Korea (307.8 per 100,000). Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the molecular diagnosticsr in the region.

On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment

Key Players:

The top key players in global molecular diagnostics market F. Hoffmann-La Roche Ltd. (U.S.), QIAGEN N.V. (the Netherlands), Hologic, Inc. (U.S.), Grifols (Spain), Abbott (U.S.), Siemens Healthcare GmbH(Germany), Bio-Rad Laboratories, Inc.(US), BD (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid (U.S.).

Market Highlights:

The reagents used in molecular diagnostics play important role in primary diagnosis and treatment of diseases at molecular level. The instruments like PCR and next generation sequencing has shown reliable test results and are rapid in nature which resulting increasing demand in central laboratories diagnostics institutes. Moreover, molecular testing tools are providing better alternatives in detecting in infectious viral, bacterial and other pathogens. All these factors are responsible for growth of the market positively. Furthermore, increasing prevalence of infectious diseases like influenza and human papillomavirus and others also boost the growth of the market. On the other hand, higher price of molecular diagnostic kits may hinder the growth of the market.

According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compare with developing countries. Moreover, adoption of unhealthy lifestyle, exposure to harmful radiation, increasing geriatric population and increasing governmental initiatives also contributed in the growth of the market.

TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1171 .

Competitive Analysis:

Bio-Rad Laboratories, Inc. is the US headquartered company which develops, manufactures and market a wide range of products for molecular diagnostic and research. In Feb 2016, the company got approval for QX200, Droplet which are the first digital PCR systems. Bio-rad has a wide range of molecular diagnostic tools.

Abbott laboratories, incorporated in 1990 and headquartered in Illinois, USA, Abbott Laboratories focuses on discovery, development, manufacture, and sale of health care products. The company operates through four reportable segments namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. In April, 2016 it received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients.

Segmentation:

The global molecular diagnostics market is segmented on the basis of techniques, applications and end users. Based on the techniques, it is segmented into PCR (Polymerase chain reaction) and real-time PCR, fluorescence in-situ hybridization, microarray, transcription-mediated amplification, and next-generation sequencing. Based on applications, it is segmented intoinfectious diseases, oncology, blood screening, genetic testing, pharmacogenomics, human leukocyte antigen typing, coagulation, others. And based on end users, it is segmented into hospitals, diagnostic laboratories, academics and research institutions.

Major TOC of Molecular Diagnostics Market:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Molecular Diagnostics Market, By Type of Technique

Chapter 7. Global Molecular Diagnostics Market, By Applications

Chapter 8. Global Molecular Diagnostics Market, By End User

Chapter 9. Global Molecular Diagnostics Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

…CONTINUED

AVAIL DISCOUNT REPORT @ https://www.marketresearchfuture.com/check-discount/1171 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]

Posted by Vivian Dsena on Tuesday February 06 2018, 1:15 PM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0